Holen Sie sich die Stockscreener-App
5.60
0.78%
-0.0443
Schlusskurs vom Vortag:
$5.6443
Offen:
$4.99
24-Stunden-Volumen:
6,785
Relative Volume:
0.95
Marktkapitalisierung:
$93.57M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+13.10%
1M Leistung:
-10.83%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.99
$5.60
1-Wochen-Bereich:
$4.7237
$5.6443
52-Wochen-Spanne:
$4.7237
$6.85
Bioharvest Sciences Inc Stock (BHST) Company Profile
Firmenname
Bioharvest Sciences Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BHST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
5.60 | 93.57M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.17 | 125.39B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
719.14 | 79.10B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
668.79 | 40.58B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
274.33 | 35.43B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.14 | 29.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-18 | Eingeleitet | Maxim Group | Buy |
Bioharvest Sciences Inc Aktie (BHST) Neueste Nachrichten
When Will BioHarvest Sciences Inc. (CSE:BHSC) Become Profitable? - Simply Wall St
BioHarvest Sciences reports material change - Investing.com India
BioHarvest Sciences Appoints Sharon Malka to Board of Directors - TipRanks
BioHarvest Sciences reports material change By Investing.com - Investing.com UK
BioHarvest Sciences appoints veteran technology leader to board of directors - Proactive Investors USA
BioHarvest Announces Appointment of Sharon Malka to Board of Directors - Newsfile
Bioharvest Sciences Inc. Appoints Sharon Malka as Independent Director -January 22, 2025 at 08:34 am EST - Marketscreener.com
OTC Markets Group Announces Quarterly Index Performance and Rebalancing - GlobeNewswire Inc.
BioHarvest Sciences Strengthens Board with Healthcare Industry Veteran Sharon Malka - StockTitan
BioHarvest Sciences positioned for ‘legacy year’ in 2025, building on momentum with new innovations and strategic collaborations - Proactive Investors USA
BioHarvest Sciences doubles VINIA business, eyes growth By Investing.com - Investing.com Australia
CSE Bulletin: NV Issuer DesignationBioHarvest Sciences Inc. (BHSC) - Newsfile
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growth - Proactive Investors UK
BioHarvest Sciences Unveils Strategic Growth Initiatives with New CDMO Division - TipRanks
BioHarvest Sciences doubles VINIA business, eyes growth - Investing.com
BioHarvest Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
BioHarvest Sciences (NASDAQ:BHST) Earns Buy Rating from Analysts at Maxim Group - Defense World
Maxim Group sets Buy rating on BioHarvest Sciences shares, cites robust growth - Investing.com India
BioHarvest Sciences (NASDAQ:BHST) Now Covered by Maxim Group - MarketBeat
BioHarvest Sciences CEO discusses Tate & Lyle partnershipICYMI - Proactive Investors USA
Clean the SkyBotanical Sweetener Partnerships - Trend Hunter
BioHarvest Sciences shares keep buy rating, partnership drives optimism By Investing.com - Investing.com South Africa
BioHarvest Sciences shares keep buy rating, partnership drives optimism - Investing.com India
Tate & Lyle and BioHarvest collaboration to pioneer next gen plant-based ingredients - Food and Drink Technology
BioHarvest Sciences Partners with Tate & Lyle to Develop Sustainable Plant-Based Sweeteners - Proactive Investors USA
BioHarvest Sciences partners with Tate & Lyle to advance plant-based sweeteners - Proactive Investors UK
EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Molecules - AOL
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology - Newsfile
Tate & Lyle Partners with BioHarvest Sciences to Revolutionize Plant-Based Sweeteners Using Breakthrough Technology - StockTitan
BHST News Today | Why did BioHarvest Sciences stock go up today? - MarketBeat
HC Wainwright Initiates Coverage on BioHarvest Sciences (NASDAQ:BHST) - Defense World
CNVCF (BioHarvest Sciences) GF Value Rank : 2 (As of Nov. 30, 2024) - GuruFocus.com
BioHarvest Sciences expands VINIA product line with launch of SuperFood Infused Teas - Proactive Investors Australia
BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Misses Revenue Estimates - MSN
BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion - GuruFocus.com
BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
BioHarvest reports strong response from VINIA Superfood Coffee - Comunicaffe
BioHarvest Launches VINIA SuperFood Functional Tea Line - Sault This Week
Finanzdaten der Bioharvest Sciences Inc-Aktie (BHST)
Es liegen keine Finanzdaten für Bioharvest Sciences Inc (BHST) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.66%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):